SUBSCRIBE
SUBSCRIBE
News   Deals

Sanofi Pasteur (JOBS) Purchases Rights to Syntiron LLC’s MRSA Vaccine; Sanofi Will Pay Syntiron Upfront Fee, Research Capital, and Several Milestone Payments That Could Reach $149 Million

December 16, 2009 | 
1 min read
Bookmark and Share

Bloomberg -- Sanofi-Aventis SA bought rights to a vaccine designed to prevent infection with Staphylococcus bacteria from closely held U.S. biotechnology company Syntiron.
Mergers & acquisitions
MORE ON THIS TOPIC
Brain shaped maze. Conceptual image of science and medicine. 3D illustration.
ALS
Lilly Deepens ALS Pipeline With $415M Alchemab Licensing Deal
May 6, 2025
 · 
2 min read
 · 
Tristan Manalac
Business and financial crisis vector concept with businessman falling down the hole. Symbol of market crash, recession, risk, bankruptcy and loss. Eps10 illustration.
Mergers & acquisitions
Kronos Accepts $35M Concentra Buyout as Walls Close In
May 2, 2025
 · 
2 min read
 · 
Annalee Armstrong
Creative design. Desperate employee, office worker standing near question mark symbolizing business struggles, options. Choosing strategy for achieving goal. Concept of business, career development
Earnings
Tariffs Keep Biogen Execs Busy in Q1 but Impacts Expected To Be Minimal
May 1, 2025
 · 
3 min read
 · 
Annalee Armstrong
Paying double wages or giving double money, greed and lust, double work for double wages, one person splitting into two and claiming both
Deals
Novartis Strikes on M&A, Leading a Line of Big Pharmas With Cash to Spend
April 30, 2025
 · 
5 min read
 · 
Annalee Armstrong